Intestinal Perforation in Colorectal Cancers Treated with Bevacizumab (Avastin®)
Young Il Choi, Seung Hyun Lee, Byung Kwon Ahn, Sung Uhn Baek, Seun Ja Park, Yang Soo Kim, Seong Hoon Shin
Cancer Res Treat. 2008;40(1):33-35.   Published online 2008 Mar 31     DOI: https://doi.org/10.4143/crt.2008.40.1.33
Citations to this article as recorded by Crossref logo
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)
Jai N. Patel, Chen Jiang, Kouros Owzar, Daniel L. Hertz, Janey Wang, Flora A. Mulkey, William K. Kelly, Susan Halabi, Yoichi Furukawa, Cameron Lassiter, Susan G. Dorsey, Paula N. Friedman, Eric J. Small, Michael A. Carducci, Michael J. Kelley, Yusuke Naka
The Pharmacogenomics Journal.2024;[Epub]     CrossRef
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
Akihiko Ueda, Hidemichi Watari, Masaki Mandai, Shunichi Fukuhara, Yasuo Sugitani, Kiyoko Ogino, Shuichi Kamijima, Takayuki Enomoto
Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placement
Pratima Dibba, Emmy Ludwig, Delia Calo, Hans Gerdes, Arnold Markowitz, Moshe Shike, Mark Schattner, Robin Mendelsohn
Surgical Endoscopy.2021; 35(6): 2976.     CrossRef
Evolution of pediatric gastrointestinal ulcer disease: Is acute surgical intervention relevant?
Alyssa D. Brown, Michael D. Traynor, D. Dean Potter, Michael B. Ishitani, Christopher R. Moir, Paul J. Galardy, Denise B. Klinkner
Journal of Pediatric Surgery.2021; 56(10): 1870.     CrossRef
A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed
Shuncong Wang, Yewei Liu, Yuanbo Feng, Jian Zhang, Johan Swinnen, Yue Li, Yicheng Ni
Cancers.2019; 11(11): 1782.     CrossRef
Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancer
Motohiro Tamiya, Hidekazu Suzuki, Takayuki Shiroyama, Ayako Tanaka, Naoko Morishita, Norio Okamoto, Kenichi Sakai, Hironori Shigeoka, Kunimitsu Kawahara, Tomonori Hirashima
Investigational New Drugs.2018; 36(4): 696.     CrossRef
A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis
Shinya Urakawa, Daisuke Sakai, Yasuhiro Miyazaki, Toshihiro Kudo, Aya Katou, Chiaki Inagaki, Koji Tanaka, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Kiyokazu Nakajima, Shuji Takiguchi, Taroh Satoh, Masaki Mori, Yuichiro Doki
Surgical Case Reports.2017;[Epub]     CrossRef
Sigmoid Colon Perforation Related to Bevacizumab in a Patient With Glioblastoma
Mehmet Akif Ozturk, Baran Erdik, Orhan Onder Eren
American Journal of Therapeutics.2016; 23(1): e241.     CrossRef
When a good call leads to a bad connection: colovesical fistula in colorectal cancer treated with bevacizumab
Jeffrey Chen, Roger D. Smalligan, Suhasini Nadesan
Hospital Practice.2016; 44(3): 120.     CrossRef
Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials
Zexing Wang, Jun Zhang, Liang Zhang, Pengying Liu, Yamin Xie, Qin Zhou
Journal of Chemotherapy.2016; 28(4): 328.     CrossRef
Safety and Efficacy of Palliative Colorectal Stent Placement Using a Nasal Endoscope Technique
Taishi Hata, Shiro Hayashi, Masakazu Miyake, Shunji Morita, Keizo Dono
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2015; 25(3): 262.     CrossRef
Multidetector-row CT of tumour–bowel fistula: Experience at a tertiary cancer centre
S.H. Tirumani, A.B. Shinagare, J.P. Jagannathan, K.M. Krajewski, N.H. Ramaiya
Clinical Radiology.2014; 69(2): e100.     CrossRef
Bowel perforation associated with temsirolimus use in a recently irradiated patient
Claire M. Mach, Anze Urh, Matthew L. Anderson
American Journal of Health-System Pharmacy.2014; 71(11): 919.     CrossRef
Complications of Targeted Drug Therapies for Solid Malignancies: Manifestations and Mechanisms
Richard G. Abramson, Vandana G. Abramson, Emily Chan, Leora Horn, Vicki L. Keedy, William Pao, Jeffrey A. Sosman
American Journal of Roentgenology.2013; 200(3): 475.     CrossRef
Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period
S S Wickremasinghe, J Xie, R H Guymer, T Y Wong, R Kawasaki, S Qureshi
Eye.2012; 26(7): 958.     CrossRef
Intraperitoneal bevacizumab combined with cytoreductive surgery: a pre-clinical study of tolerance and pharmacokinetics in an animal model
Guillaume Passot, Aurélien Dupré, Michel Rivoire, Faheez Mohamed, Naoual Bakrin, Olivier Glehen
Clinical and Translational Oncology.2012; 14(12): 931.     CrossRef
Influence of Modern Systemic Therapies as Adjunct to Cytoreduction and Perioperative Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis: A Multicenter Study
Terence C. Chua, David L. Morris, Akshat Saxena, Jesus Esquivel, Winston Liauw, Joerg Doerfer, Christoph-Thomas Germer, Alexander G. Kerscher, Joerg O. W. Pelz
Annals of Surgical Oncology.2011; 18(6): 1560.     CrossRef
A Case of Severe Bevacizumab-induced Ischemic Pancolitis, Treated with Conservative Management
Ha Ni Lee, Myung-Ah Lee, Sang Woo Kim, Yejee Lim, Hwayoung Lee, Hae Min Lee, Hye Sung Won, Sang-Hoon Chun
The Korean Journal of Gastroenterology.2011; 58(1): 42.     CrossRef
Perforated Rectal Cancer Presenting as Fournier's Gangrene
John Alfred Carr
Journal of Clinical Oncology.2010; 28(30): e605.     CrossRef